Uveitis in Patients with Multiple Sclerosis in Clinical Trials of Fingolimod Incidence, Prevalence, and Impact on Disease Course

Lim Lyndell L.; Silva Diego G.; Lo Tiffany C.; Pimentel Ronald S.; Butzkueven Helmut; Hall Anthony J.

首页> 外文期刊>Ophthalmology >Uveitis in Patients with Multiple Sclerosis in Clinical Trials of Fingolimod Incidence, Prevalence, and Impact on Disease Course

【24h】

Uveitis in Patients with Multiple Sclerosis in Clinical Trials of Fingolimod Incidence, Prevalence, and Impact on Disease Course

机译：患有多发性硬化症的患者葡萄膜炎发病率，患病率和对疾病课程的影响

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Purpose: To determine the incidence and prevalence of uveitis and its effect on multiple sclerosis (MS) disease activity and outcomes in patients with MS who participated in the fingolimod clinical trial program.

机译：目的：确定葡萄膜炎的发病率和患病率和对参加Fingolimod临床试验计划的MS患者的多发性硬化（MS）疾病活动和结果的影响。

著录项

来源
《Ophthalmology》 |2019年第3期|共7页
作者
Lim Lyndell L.; Silva Diego G.; Lo Tiffany C.; Pimentel Ronald S.; Butzkueven Helmut; Hall Anthony J.;
展开▼
作者单位

Univ Melbourne Ctr Eye Res Australia Parkville Vic Australia;

Novartis Pharma AG Basel Switzerland;

Univ Melbourne Ctr Eye Res Australia Parkville Vic Australia;

Novartis Pharma AG Basel Switzerland;

Monash Univ MSNI Dept Neurosci Cent Clin Sch Alfred Campus Clayton Vic Australia;

Eye Surg Associates East Melbourne Vic Australia;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类眼科学;
关键词

相似文献

外文文献
中文文献
专利

1. Uveitis in Patients with Multiple Sclerosis in Clinical Trials of Fingolimod Incidence, Prevalence, and Impact on Disease Course [J] . Lim Lyndell L., Silva Diego G., Lo Tiffany C., Ophthalmology . 2019,第3期

机译：患有多发性硬化症的患者葡萄膜炎发病率，患病率和对疾病课程的影响
2. Prevalence and incidence of uveitis in a large multiple sclerosis cohort from the fingolimod clinical trials [J] . Lo Tiffany Ching Shen, Silva Diego G., Whitford Cecily, Investigative ophthalmology & visual science . 2017,第8期

机译：来自Fingolimod临床试验的大多发性硬化队列中葡萄炎患病率和发病率
3. Prevalence and incidence of uveitis in a large multiple sclerosis cohort from the fingolimod clinical trials [J] . Lo Tiffany Ching Shen, Silva Diego G., Whitford Cecily, Investigative ophthalmology & visual science . 2017,第8期

机译：来自Fingolimod临床试验的大多发性硬化队列中葡萄炎患病率和发病率
4. THE VALIDATED PREVALENCE OF MULTIPLE SCLEROSIS AND MOTOR NEURONE DISEASE IN AUSTRALIAN VIETNAM VETERANS [C] . Michelle McPherson, Phil Trickett, Paul Magnus, International symposium on halogenated environmental organic pollutants and persistent organic pollutants and POPs;DIOXIN;DIOXIN 2001;POPs . 2001

机译：在澳大利亚越战退伍军人中，多发性硬化症和运动神经元疾病的有效率
5. Aging and Disease-modifying Therapies in Multiple Sclerosis: Insights from Clinical Trials and Registries [D] . Zhang, Yinan. 2021

机译：多发性硬化症中的衰老和疾病改性疗法：临床试验和注册管理机构的见解
6. Incidence of uveitis and macular edema among patients taking fingolimod 0.5 mg for multiple sclerosis [O] . Scott Joseph Sonne, Bradley Thomas Smith 2020

机译：蜂巢和黄斑水肿的发病率患者患者患者为0.5毫克进行多发性硬化症
7. Incidence of Uveitis and Macular Edema among Patients taking Fingolimod 0.5mg for Multiple Sclerosis [O] . Scott Joseph Sonne, Bradley Thomas Smith 2020

机译：蜂巢发病率和黄斑水肿，患者患者患者为多发性硬化症患者0.5mg

Uveitis in Patients with Multiple Sclerosis in Clinical Trials of Fingolimod Incidence, Prevalence, and Impact on Disease Course

摘要

著录项

相似文献

相关主题

期刊订阅